Envista Holdings Corporation (NYSE:NVST – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the fifteen ratings firms that are currently covering the firm, MarketBeat Ratings reports. Seven analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating on the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $27.75.
A number of research analysts recently weighed in on NVST shares. Morgan Stanley set a $19.00 price objective on shares of Envista in a report on Friday, February 6th. UBS Group raised their price target on shares of Envista from $22.00 to $25.00 and gave the company a “neutral” rating in a research report on Tuesday, February 3rd. Leerink Partners set a $35.00 price target on shares of Envista and gave the stock an “outperform” rating in a research note on Friday, February 6th. Mizuho upped their price objective on Envista from $24.00 to $27.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 10th. Finally, Wall Street Zen upgraded Envista from a “buy” rating to a “strong-buy” rating in a research note on Monday, January 26th.
Get Our Latest Report on Envista
Insiders Place Their Bets
Institutional Trading of Envista
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Farther Finance Advisors LLC boosted its position in shares of Envista by 317.6% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,349 shares of the company’s stock worth $27,000 after acquiring an additional 1,026 shares in the last quarter. Caitong International Asset Management Co. Ltd raised its position in shares of Envista by 16,711.1% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock worth $31,000 after acquiring an additional 1,504 shares in the last quarter. Allworth Financial LP lifted its stake in Envista by 75.4% during the fourth quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock worth $39,000 after purchasing an additional 776 shares during the last quarter. UMB Bank n.a. boosted its holdings in Envista by 46.1% in the fourth quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock valued at $44,000 after purchasing an additional 636 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Envista by 73.1% in the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock valued at $44,000 after purchasing an additional 949 shares in the last quarter.
Envista Trading Down 4.0%
NVST traded down $1.11 during mid-day trading on Friday, hitting $26.82. 2,878,784 shares of the stock were exchanged, compared to its average volume of 3,101,341. The firm’s fifty day moving average is $25.79 and its two-hundred day moving average is $22.41. Envista has a 1-year low of $14.22 and a 1-year high of $30.42. The company has a market cap of $4.40 billion, a PE ratio of 95.79, a PEG ratio of 1.91 and a beta of 0.95. The company has a current ratio of 2.38, a quick ratio of 2.04 and a debt-to-equity ratio of 0.47.
Envista (NYSE:NVST – Get Free Report) last released its earnings results on Thursday, February 5th. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.32 by $0.06. Envista had a return on equity of 6.54% and a net margin of 1.73%.The business’s quarterly revenue was up 15.0% on a year-over-year basis. During the same period in the prior year, the company posted $0.24 earnings per share. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Equities analysts forecast that Envista will post 1 earnings per share for the current fiscal year.
Envista Company Profile
Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.
Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.
See Also
- Five stocks we like better than Envista
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.
